Methods for treating epithelian mesenchymal transition related diseases
View Patent ↗Certain embodiments are directed to methods of treating chronic lung diseases in a subject comprising administering to a subject diagnosed with, exhibiting symptoms of, or at risk of developing a chronic lung disease a therapeutically effective amount of a BRD4 inhibitor or a CDK9 inhibitor to the subject.
1. A method of treating epithelial-mesenchymal transition (EMT) lung fibrosis in a subject comprising administering a therapeutically effective amount of a small molecule BRD4 inhibitor to a subject having or at risk of developing EMT lung fibrosis.
2. The method of claim 1 , wherein the BRD4 inhibitor is administered by inhalation or instillation.
3. The method of claim 1 , wherein the BRD4 inhibitor is administered at a dose of 150 to 500 mg/day.
4. The method of claim 1 , wherein the BRD4 inhibitor is JQ1.